SCM
HAE icon

Sio Capital Management’s Haemonetics HAE Stock Holding History

Sio Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4M Buy
220,672
+128,041
+138% +$8.34M 1.78% 17
2025
Q4 		$7.42M Sell
92,631
-105,404
-53% -$7.08M 1.17% 24
2025
Q3 		$9.65M Buy
+198,035
New +$12.3M 2.44% 14
2025
Q2 		– Sell
-133,966
Closed -$8.51M – 55
2025
Q1 		$8.51M Buy
+133,966
New +$9.11M 2.54% 13

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sio Capital Management's HAE Position: Q1 2026 in Review

Sio Capital Management increased its Haemonetics (HAE) stake by 138% in Q1 2026, buying an estimated $8.34M and bringing the position to 220,672 shares worth $12.4M. The position accounts for 1.78% of the portfolio, ranked #17.

Sio Capital Management first reported a position in HAE in Q1 2025 and has held it in 4 quarters since. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Sio Capital Management held 220,672 shares of Haemonetics worth $12.4M as of Q1 2026.
  • Sio Capital Management bought 128,041 Haemonetics shares in Q1 2026, an estimated $8.34M.
  • Haemonetics made up 1.78% of Sio Capital Management's portfolio in Q1 2026, its #17 holding.
  • Sio Capital Management first reported a position in Haemonetics in Q1 2025 and has held it in 4 quarters since.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Sio Capital Management's 13F filing for Q1 2026, filed 14 May 2026.